Carlyle Group Inc.
Institutional investor · Portfolio as of Q2 2023
Top Holdings26 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
QUIDELORTHO CORP | 12.5M | $1B | 36.8% | $100.03 | -18.57% | 5 qtrssince 2022-Q2 | Unchanged 0 |
ZOOMINFO TECHNOLOGIES INC | 36.7M | $930.9M | 33.2% | $50.72 | -48.58% | 13 qtrssince 2020-Q2 | Unchanged 0 |
MKS INC | 3.5M | $376.5M | 13.4% | $82.62 | +26.14% | 4 qtrssince 2022-Q3 | Decreased 0 |
VITRU LTD | 6.2M | $100.1M | 3.6% | — | — | 12 qtrssince 2020-Q3 | Unchanged 0 |
VERONA PHARMA PLC | 2.5M | $51.9M | 1.8% | — | — | 2 qtrssince 2023-Q1 | Unchanged 0 |
PHATHOM PHARMACEUTICALS INC | 3.5M | $50.1M | 1.8% | $7.87 | +71.31% | 2 qtrssince 2023-Q1 | Increased 55 |
GETTY IMAGES HOLDINGS INC | 10M | $48.7M | 1.7% | $5.55 | -11.17% | 3 qtrssince 2022-Q4 | Decreased 0 |
GDS Holdings Ltd. Sponsored ADR Class A | 4.1M | $44.8M | 1.6% | $20.58 | -46.93% | 3 qtrssince 2022-Q4 | Unchanged 0 |
VERA THERAPEUTICS INC | 2.4M | $38.8M | 1.4% | $7.44 | +128.36% | 2 qtrssince 2023-Q1 | Decreased 0 |
HILLEVAX INC | 1.8M | $31.5M | 1.1% | — | — | 2 qtrssince 2023-Q1 | Unchanged 0 |
| 2.7M | $17.7M | 0.6% | — | — | 2 qtrssince 2023-Q1 | Increased 51 | |
INVITATION HOMES INC | 477,500 | $16.4M | 0.6% | $27.70 | +12.02% | 2 qtrssince 2023-Q1 | Unchanged 0 |
SEACOR MARINE HLDGS INC | 1.3M | $15M | 0.5% | $10.73 | +6.22% | 19 qtrssince 2018-Q4 | Increased 40 |
Jasper Therapeutics, Inc. | 8.8M | $11.8M | 0.4% | — | — | — | — |
CUBESMART | 220,500 | $9.8M | 0.4% | $33.47 | +17.51% | 4 qtrssince 2022-Q3 | Unchanged 0 |
SPRUCE BIOSCIENCES INC | 2.9M | $6.2M | 0.2% | — | — | — | — |
| 2.1M | $5.1M | 0.2% | — | — | 2 qtrssince 2023-Q1 | Unchanged 0 | |
SOLENO THERAPEUTICS INC | 1.2M | $5.1M | 0.2% | $2.21 | +90.05% | 2 qtrssince 2023-Q1 | Unchanged 0 |
SMART SH GLOBAL LTD | 4.8M | $4.7M | 0.2% | $1.12 | -12.50% | 5 qtrssince 2022-Q2 | Unchanged 0 |
eFFECTOR Therapeutics, Inc. | 4.8M | $4M | 0.1% | $8.74 | +117.28% | 2 qtrssince 2023-Q1 | Unchanged 0 |
Carlyle Group Inc. manages $2.8B across 26 positions as of Q2 2023. Top holdings: QDEL (36.8%), GTM (33.2%), MKSI (13.4%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 1.5/5.0.
Exited 4, increased 3, trimmed 3. Top move: PHAT (INCREASED, conviction 55). Portfolio: $2.8B across 26 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer